Equities Analysts Offer Predictions for UNH FY2024 Earnings

UnitedHealth Group Incorporated (NYSE:UNH) – Zacks Research decreased their FY2024 earnings per share estimates for shares of UnitedHealth Group in a report released on Wednesday, November 13th. Zacks Research analyst D. Chatterjee now forecasts that the healthcare conglomerate will earn $27.54 per share for the year, down from their previous estimate of $27.61. The consensus estimate for UnitedHealth Group’s current full-year earnings is $27.61 per share. Zacks Research also issued estimates for UnitedHealth Group’s Q3 2025 earnings at $7.93 EPS, FY2025 earnings at $30.11 EPS, Q2 2026 earnings at $8.09 EPS and FY2026 earnings at $34.03 EPS.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same period last year, the business posted $6.56 EPS. UnitedHealth Group’s revenue was up 9.2% compared to the same quarter last year.

A number of other analysts also recently commented on the company. Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Stephens dropped their price objective on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. HSBC cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. TD Cowen upped their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Finally, Morgan Stanley cut their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Three analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Trading Down 0.2 %

Shares of UNH stock opened at $592.23 on Friday. The firm’s fifty day simple moving average is $582.84 and its 200 day simple moving average is $549.06. UnitedHealth Group has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $545.02 billion, a P/E ratio of 38.58, a price-to-earnings-growth ratio of 1.78 and a beta of 0.58.

Institutional Trading of UnitedHealth Group

Institutional investors have recently added to or reduced their stakes in the company. China Universal Asset Management Co. Ltd. raised its position in shares of UnitedHealth Group by 20.6% in the 1st quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock valued at $5,376,000 after buying an additional 1,857 shares in the last quarter. Quent Capital LLC lifted its stake in UnitedHealth Group by 5.5% during the first quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock worth $2,076,000 after purchasing an additional 217 shares during the last quarter. 1ST Source Bank raised its holdings in shares of UnitedHealth Group by 1.8% during the 1st quarter. 1ST Source Bank now owns 1,681 shares of the healthcare conglomerate’s stock worth $832,000 after buying an additional 30 shares in the last quarter. M&G Plc acquired a new stake in UnitedHealth Group in the first quarter valued at about $239,713,000. Finally, Mizuho Markets Cayman LP acquired a new position in UnitedHealth Group during the first quarter worth about $343,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.